Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COLLEGIUM PHARMACEUTICAL, INC.

(COLL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about COLLEGIUM PHARMACEUTICAL, INC.
2021Collegium Pharmaceutical Enters Into $2.8 Million Settlement Framework to Resolve Opioi..
MT
2021COLLEGIUM PHARMACEUTICAL : Announces Settlement Framework to Resolve Pending Opioid-Relate..
PU
2021COLLEGIUM PHARMACEUTICAL, INC : Regulation FD Disclosure, Other Events, Financial Statemen..
AQ
2021Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation
GL
2021Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation
GL
2021Collegium Ranks as a Top Place to Work for 2021 by The Boston Globe
GL
2021Collegium Pharmaceutical Signs $25 million Share-Repurchase Agreement With Jefferies
MT
2021Needham Adjusts Price Target on Collegium Pharmaceutical to $28 from $26, Keeps Buy Rat..
MT
2021Collegium Announces $25 Million Accelerated Share Repurchase Program
AQ
2021COLLEGIUM PHARMACEUTICAL, INC : Costs Associated with Exit or Disposal Activities (form 8-..
AQ
2021UPDATE : Collegium to Participate in Upcoming Conferences
GL
2021UPDATE : Collegium to Participate in Upcoming Conferences
GL
2021Collegium Participate in Upcoming Conferences
AQ
2021HC Wainwright Adjusts Collegium Pharmaceutical PT to $26 From $28, Maintains Buy Rating
MT
2021Needham Adjusts Price Target on Collegium Pharmaceutical to $26 From $32, Maintains Buy..
MT
2021COLLEGIUM PHARMACEUTICAL : Q3 Earnings Snapshot
AQ
2021Collegium Pharmaceutical, Inc. Provides Revenue Guidance for the Year 2021
CI
2021Collegium Pharmaceutical to Seek Acquisitions
CI
2021COLLEGIUM PHARMACEUTICAL, INC Management's Discussion and Analysis of Financial Condit..
AQ
2021Collegium Reports Third Quarter Fiscal 2021 Results - Form 8-K
PU
2021Tranche Update on Collegium Pharmaceutical, Inc.'s Equity Buyback Plan announced on Aug..
CI
2021Collegium Pharmaceutical, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
2021Collegium Reports Third Quarter Fiscal 2021 Results
AQ
2021COLLEGIUM PHARMACEUTICAL : to Host Conference Call to Discuss Third Quarter 2021 Financial..
GL
2021COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Other Events (f..
AQ
2021Collegium Pharmaceutical, Inc. Announces Executive Changes
CI
2021Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference
GL
2021COLLEGIUM PHARMACEUTICAL : to Participate in Upcoming Investor Conferences
AQ
2021Top Midday Gainers
MT
2021COLLEGIUM PHARMACEUTICAL : Approves $100 Million Share Buyback Program
MT
2021COLLEGIUM PHARMACEUTICAL : Material Event (Form 8-K)
PU
2021COLLEGIUM PHARMACEUTICAL, INC : Other Events (form 8-K)
AQ
2021COLLEGIUM PHARMACEUTICAL : Announces $100 Million Share Repurchase Program
AQ
2021Collegium Pharmaceutical, Inc. announces an Equity Buyback for $100 million worth of it..
CI
2021Collegium Pharmaceutical, Inc. authorizes a Buyback Plan.
CI
2021COLLEGIUM PHARMACEUTICAL : Cantor Fitzgerald Downgrades Collegium Pharmaceutical to Neutra..
MT
2021COLLEGIUM PHARMACEUTICAL : Posts Higher Q2 Earnings, Product Revenue
MT
2021COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target t..
MT
2021COLLEGIUM PHARMACEUTICAL : Q2 Earnings Snapshot
AQ
2021COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and..
AQ
2021Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million
GL
2021Collegium Pharmaceutical, Inc. Provides Revenue Guidance for the Full Year 2021
CI
2021Collegium Pharmaceutical, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
CI
2021Collegium to Host Conference Call to Discuss Second Quarter 2021 Financial Results and ..
GL
2021Collegium Announces Publication of Real-World Data in Journal of Pain Research
GL
2021INSIDER TRENDS : Collegium Pharmaceutical Insider Exercises Options Derivative Securities,..
MT
2021COLLEGIUM PHARMACEUTICAL, INC : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
2021COLLEGIUM PHARMACEUTICAL : Departure of Directors or Certain Officers; Election of Directo..
PU
2021COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Submission of M..
AQ
2021Collegium to Participate in Upcoming Investor Conference
GL
2021INSIDER TRENDS : Collegium Pharmaceutical Insider Continues 90-Day Selling Trend
MT
2021COLLEGIUM PHARMACEUTICAL : Q1 Earnings Snapshot
AQ
2021COLLEGIUM PHARMACEUTICAL, INC : Results of Operations and Financial Condition, Change in D..
AQ
2021COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and..
AQ
2021Collegium Reports Record Quarterly Revenue of $87.7 Million
GL
2021Collegium Pharmaceutical, Inc. Reports Earnings Results for the First Quarter Ended Mar..
CI
2021Collegium Pharmaceutical, Inc. Announces Executive Change, Effective May 24, 2021
CI
2021Collegium Pharmaceutical, Inc. Announces Appointment of Colleen Tupper as Executive Vic..
CI
2021Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and P..
GL
2021INSIDER TRENDS : Insider at Collegium Pharmaceutical Sells Stock for Taxes Interrupting 90..
MT
2021COLLEGIUM PHARMACEUTICAL : Significant Insider Selling Continues at Collegium Pharmaceutic..
MT
2021INSIDER TRENDS : 90-Day Insider Buying Trend at Collegium Pharmaceutical Slowed with Sale ..
MT
2021COLLEGIUM PHARMACEUTICAL : 4Q Earnings Snapshot
AQ
2021COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and..
AQ
2021Collegium Pharmaceutical, Inc. Reports Earnings Results for the Full Year Ended Decembe..
CI
2021Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million
GL
2021Collegium Pharmaceutical, Inc. Reiterates Financial Guidance for the Full-Year 2021
CI
2021INSIDER TRENDS : Collegium Pharmaceutical Insider Disposes of Shares for Tax Slowing 90-Da..
MT
2021INSIDER TRENDS : Insider at Collegium Pharmaceutical Sells Shares for Tax Slowing 90-Day B..
MT
2021INSIDER TRENDS : Collegium Pharmaceutical Insider Makes Shares Sale for Tax Slowing 90-Day..
MT
2021COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P 600
CI
2021COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P Composite 1500
CI
2021COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P 600 Health Care
CI
2021COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P 1000
CI
2021Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and ..
GL
1  2  3  4  5Next
Upcoming event on COLLEGIUM PHARMACEUTICAL, INC.